It has been claimed in a recent report that some patients with asbestos cancer could benefit from having heated chemotherapy added to surgical treatment. The report claims that patients with mesothelioma could see their survival chances improved without any safety issues as a result of these measures.

The study was recently published in the Journal of Thoracic and Cardiovascular Surgery, and researchers involved in the research have said that adding a high dose of heated chemotherapy to the chest and abdomen during surgery for malignant mesothelioma can help to improve survival chances for the patient without any risk to the patient’s safety.

The lead author of the report was Dr Sugarbaker, MD, Chief of Thoracic Surgery at Brigham and Women’s Hospital, and Professor of Surgery at Harvard Medical School. He stated: “The exciting thing about this is that a new platform for therapy has been established.”

The researchers all said that the results of the studies so far had been encouraging, and Dr Sugarbaker added: “I think that the place where heated intraoperative chemotherapy will have the greatest impact will be on patients with the earliest stage disease at the time of chemotherapy.”

Be Sociable, Share!